LGT Fund Management »

Halozyme Therapeutics shares owned by LGT Fund Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by LGT Fund Management from 13F filings

Historical chart of LGT Fund Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by LGT Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by LGT Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.0M 88k 67.70
2025-06-30 $1.7M 34k 52.02

More positions owned by LGT Fund Management

Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Coca-Cola Company (KO)
Broadcom (AVGO)
S&p Global (SPGI)
Blackrock (BLK)
Palo Alto Networks (PANW)

View all positions for LGT Fund Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics